| (INR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 20.26B | — |
| Operating expense | — | — |
| Net income | 3.68B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, LAURUSLABS.NS returned +105.4% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +62.8% |
| 1 year | +105.4% |
| 5 years | +174.3% |
| All-time high | ₹1,816.20 (Jul 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what ₹1,000 in LAURUSLABS.NS would be worth today ›Yes. Laurus Labs Limited paid 2 dividends over the past 12 months. The most recent was ₹1.20 per share on May 8, 2026. The dividend yield is 0.13%.
Laurus Labs Limited is part of the Healthcare sector.
Laurus Labs Limited has a market cap of 973.10B INR, based on the latest quote.
Laurus Labs Limited is scheduled to report earnings on Oct 22, 2026.